Portal de Periódicos da CAPES

Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States

2017; Springer Science+Business Media; Volume: 12; Issue: 1 Linguagem: Inglês

10.1007/s11657-017-0316-5

1862-3514

Emily Durden, Lionel Pinto, Lorena López-González, Paul Juneau, Richard Barron,

Estrogen and related hormone effects

This retrospective, observational study assessed 2-year persistence and compliance by treatment, route of administration, and dosing frequency in postmenopausal women initiating a new osteoporosis therapy. Two-year persistence and compliance rates were higher in women receiving injectables compared with oral agents.